Bleeding of Unknown Cause: a Swiss Case-control Study (SWISS-BUC)
Bleeding of Unknown Cause, Insight Into a Multifactorial Bleeding Disorder: a Swiss Case-control Study
Sponsor: University Hospital, Geneva
This observational or N/A phase trial investigates Bleeding Disorder and is currently actively recruiting participants. University Hospital, Geneva leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Study Description(click to expand)Patients with bleeding of unknown cause are included. At baseline, blood will be drawn to evaluate the hemostatic profile. Findings are compared to a control group of healthy individuals. Patients and controls are followed for 3 years.
Patients with bleeding of unknown cause are included. At baseline, blood will be drawn to evaluate the hemostatic profile. Findings are compared to a control group of healthy individuals. Patients and controls are followed for 3 years.
Status Flow
Change History
7 versions recorded-
May 4, 2026 — Present [daily]
Recruiting
-
Sep 2025 — May 2026 [monthly]
Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jun 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2023 — Jun 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
The goal of this prospective cohort is to identified specific biological patterns in patients with a bleeding of unknown cause and to study the specific mechanisms of the bleeding disorder for each subset of patients.
Contact Information
- University Hospital, Geneva
For direct contact, visit the study record on ClinicalTrials.gov .